Article Cited by others

CASE SERIES

Safety and efficacy of generic drugs with respect to brand formulation

Gallelli Luca, Palleria Caterina, De Vuono Antonio, Mumoli Laura, Vasapollo Piero, Piro Brunella, Russo Emilio

Year : 2013| Volume: 4| Issue : 5 | Page no: 110-114

   This article has been cited by
 
1 Gini Index-Based Maximum Concentration and Area Under the Curve Split Points for Analysing Adverse Event Occurrence in Bioequivalence Studies
Blanca L. Torres-García,Lucila I. Castro-Pastrana,Sara Rodríguez-Rodríguez,Larisa Estrada-Marín,Beatriz Cedillo-Carvallo,Olga Guzmán-García,Alejandro Ruíz-Argüelles
Pharmaceutical Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Generic and Branded Docetaxel
Nour Al Faqeer,Lama Nazer
The Journal of Clinical Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
Oloruntoba J Oluboka,Martin A Katzman,Jeffrey Habert,Diane McIntosh,Glenda M MacQueen,Roumen V Milev,Roger S McIntyre,Pierre Blier
International Journal of Neuropsychopharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Patient-relevant outcomes associated with generic tamsulosin, levothyroxine and amphetamine in the FDA Adverse Event Reporting System: a pilot study
Sathiya Priya Marimuthu,Geetha Iyer,Jodi B Segal,Sonal Singh
Journal of Comparative Effectiveness Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations
Nour Al Faqeer,Ola Mashni,Rawan Dawoud,Asma Rumman,Esraa Hanoun,Lama Nazer
The Journal of Clinical Pharmacology. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA®) and generic novo-methylphenidate ER-C (NOVO-generic)
Angelo Fallu,Farida Dabouz,Melissa Furtado,Leena Anand,Martin A. Katzman
Therapeutic Advances in Psychopharmacology. 2016; 6(4): 237
[Pubmed]  [Google Scholar] [DOI]
7 Challenges in Improving Access to Generic Drugs in Brazil
Marcia Cristina Zago Novaretti,Simone Aquino
Journal of Health Management. 2016; 18(4): 584
[Pubmed]  [Google Scholar] [DOI]
8 Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey
Maria Elena Flacco,Lamberto Manzoli,Stefania Boccia,Anna Puggina,Annalisa Rosso,Carolina Marzuillo,Giacomo Scaioli,Maria Rosaria Gualano,Walter Ricciardi,Paolo Villari,John P.A. Ioannidis
Mayo Clinic Proceedings. 2016;
[Pubmed]  [Google Scholar] [DOI]
9 Investigation of Biowaivers for Immediate Release Formulations Containing BCS III Drugs, Acyclovir, Atenolol, and Ciprofloxacin Hydrochloride, Using Dissolution Testing
Nallagundla H. S. Reddy,Srinivas Patnala,Isadore Kanfer
AAPS PharmSciTech. 2016;
[Pubmed]  [Google Scholar] [DOI]
10 Ciprofloxacin/levofloxacin
Reactions Weekly. 2014; 1531(1): 56
[Pubmed]  [Google Scholar] [DOI]

 

Read this article